Abbisko Therapeutics

Abbisko Therapeutics

Latest funding
$70,000,000
Venture capital (Series C) - 2020
QiMing Venture Partners Jianxin Capital Temasek +1
$28,000,000
Venture capital (Series A) - 2017
Lilly Asia Ventures Sinopharm Capital Jianxin Capital +1
Team Size
1–10
Employees
Location
Headquarters
$70,000,000 Venture capital (Series C)
DealStreetAsia

Chinese biopharma firm Abbisko closes $70m Series C round led by Temasek